Authors demonstrate process of misdiagnosis to improve the understanding of congenital heart defect

Children

In a new publication from Cardiovascular Innovations and Applications, Lei Zhang, Tiewei Lv, Xiaoyan Liu, Chuan Feng, Min Zheng, Jie Tian and Huichao Sun from the Children’s Hospital of Chongqing Medical University, Chongqing, China and the Chongqing Key Laboratory of Pediatrics, Chongqing, China consider a case of pediatric heart failure caused by the anomalous origin of the left coronary artery from the pulmonary artery.

A female patient aged 3 months and 10 days were admitted to the cardiology department due to symptoms of heart failure. According to the echocardiography results, the patient received a diagnosis of primary endocardial fibroelastosis and was treated with γ-globulin, prednisone, digoxin, and diuretics.

Coronary computed tomographic angiography and coronary angiography were performed as there was no improvement after 2 months of treatment. Finally, the patient received a diagnosis of anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA).

ALCAPA is a rare congenital heart defect that can cause severe heart failure during infancy and is easily misdiagnosed clinically. In this report, the authors demonstrate the process of misdiagnosis of the case and review the relevant literature, to improve the understanding and early diagnosis of ALCAPA.

Compscript Ltd

Journal reference:

Sun, H., et al. (2020) A Case of Pediatric Heart Failure Caused by Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Case Report and Literature Review. Cardiovascular Innovations and Applications. doi.org/10.15212/CVIA.2019.0585.

Products You May Like

Articles You May Like

Gesture and speech go hand-in-hand in twins’ early language development, show studies
Gene Therapy Fixes Rare Type of Deadly Immune Deficiency
Phase III Results Put Novel Asthma Biologic on Target for Approval
CDC says 28 blood clot cases, 3 deaths may be linked to J&J Covid vaccine
‘It’s a big deal’ for America’s push to reopen, says NIH Director on Pfizer vaccine approval for adolescents

Leave a Reply

Your email address will not be published. Required fields are marked *